For decades, lithium has been best known as a mood stabilizer prescribed for bipolar disorder. But a wave of new research is positioning the simple metal in an entirely different light: as a potential shield against Alzheimer’s disease. A landmark 2024 study from Harvard Medical School, combined with a growing body of epidemiological evidence, suggests that low doses of lithium may help preserve memory and slow the brain changes that lead to dementia.
The findings have reignited interest in one of medicine’s oldest drugs and opened a new conversation about brain aging, micronutrients, and how we might protect cognitive health long before symptoms appear.
The Harvard Discovery That Changed the Conversation
In August 2024, a research team led by neuroscientist Bruce Yankner at Harvard Medical School published a striking paper in the journal Nature. The study reported that the brains of people with mild cognitive impairment and Alzheimer’s disease contained significantly lower levels of lithium compared with healthy brains. More importantly, lithium appeared to be sequestered, or trapped, by amyloid plaques — the sticky protein clumps long associated with Alzheimer’s pathology.
When the researchers gave aging mice a low dose of lithium orotate, a form of the mineral that resists being captured by amyloid, the animals showed remarkable improvements. Their memory function was preserved, inflammation in the brain dropped, and the buildup of amyloid and tau proteins slowed dramatically.
According to Yankner’s team, the results suggest that lithium may function as a previously unrecognized trace nutrient that the brain needs to maintain healthy neuronal communication. When levels fall too low, the cascade leading to Alzheimer’s may begin years before any clinical symptoms appear.
What the Population Data Shows
The Harvard work did not emerge in isolation. For more than a decade, epidemiologists have noted unusual patterns in regions where naturally occurring lithium appears in drinking water.
A 2017 Danish study published in JAMA Psychiatry analyzed data from more than 800,000 people and found that those living in areas with higher trace lithium levels in tap water had lower rates of dementia. Similar associations have been reported in Texas, Greece, and Japan, where regional differences in lithium exposure correlate with differences in suicide rates and neurodegenerative disease incidence.
These observational studies cannot prove cause and effect. They can, however, point to biological signals worth investigating — and the new mechanistic work from Harvard now offers a plausible explanation for what those signals might mean.
How Lithium May Protect the Brain
Researchers studying lithium’s neurological effects have identified several pathways by which the mineral may influence brain health:
Inhibiting GSK-3 Activity
Lithium inhibits an enzyme called glycogen synthase kinase-3, or GSK-3. Overactive GSK-3 contributes to the abnormal tangling of tau protein, a process central to Alzheimer’s disease. By dampening GSK-3, lithium may help keep tau in its healthy form.
Supporting Neurogenesis and Synaptic Plasticity
Animal and cell studies indicate that lithium can promote the growth of new neurons and strengthen the connections between existing ones, a process essential for memory and learning.
Reducing Neuroinflammation
Chronic low-grade inflammation in the brain is increasingly recognized as a driver of cognitive decline. Lithium appears to calm inflammatory signaling in microglia, the brain’s resident immune cells.
Promoting Autophagy
Lithium has been shown to enhance autophagy, the cellular housekeeping process that removes damaged proteins and organelles. In the context of Alzheimer’s, that may help clear amyloid and tau before they accumulate.
High Dose vs. Low Dose: An Important Distinction
The lithium prescribed for bipolar disorder is dosed in the hundreds of milligrams per day and requires regular blood monitoring due to the risk of kidney, thyroid, and neurological side effects. The doses being studied for brain protection are very different. Researchers are exploring microdoses, sometimes a thousand times smaller than psychiatric doses, that are closer to what people naturally consume through food and water.
The form also matters. Lithium orotate, the version used in the Harvard mouse study, is being investigated because it appears less likely to be sequestered by amyloid plaques. Lithium carbonate, the standard psychiatric preparation, behaves differently in the body.
Despite encouraging signals, low-dose lithium is not yet an approved treatment or recognized supplement strategy for Alzheimer’s prevention. The National Institute on Aging continues to fund clinical trials evaluating whether subtherapeutic lithium doses can slow cognitive decline in older adults at risk of dementia, but definitive human evidence is still years away.
What This Means for Brain Health Today
Even without a clear supplement recommendation, the lithium research underscores broader principles that align with what scientists already know about protecting cognition with age.
The Alzheimer’s Association notes that modifiable factors — including cardiovascular health, physical activity, sleep, social engagement, and a nutrient-rich diet — collectively influence a significant share of dementia risk. The MIND and Mediterranean dietary patterns, which emphasize leafy greens, berries, nuts, fish, and whole grains, have been linked in observational studies to slower cognitive aging.
Trace minerals matter too. Adequate intake of zinc, magnesium, selenium, and B vitamins supports neuronal function, and emerging research on lithium suggests it may eventually join that list of micronutrients with a meaningful role in brain resilience.
The Bottom Line
The story of low-dose lithium and Alzheimer’s is one of cautious optimism. A drug that has been used in psychiatry for more than 70 years is now being reexamined as a possible tool for protecting the aging brain, and the mechanisms are beginning to make biological sense. The Harvard work, the epidemiological patterns, and the long history of safe low-dose use combine to make this one of the most intriguing avenues in dementia research.
What is not yet clear is whether routine supplementation would benefit healthy adults, who would benefit most, and at what dose. Until ongoing clinical trials provide answers, the most evidence-backed steps for brain health remain the familiar ones: managing blood pressure and blood sugar, staying physically active, sleeping well, eating a brain-supportive diet, and staying mentally and socially engaged.
People interested in lithium specifically should not start over-the-counter lithium supplements without medical guidance. Even low doses can interact with medications and affect thyroid and kidney function in some individuals.
Disclosure: This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before making changes to your health regimen.